Back to top

Image: Bigstock

Add These 4 Top-Performing Liquid Stocks to Maximize Returns

Read MoreHide Full Article

Key Takeaways

  • Stocks like ELF, HNGE, MTSI and SMTC were screened for strong liquidity and asset efficiency.
  • The screen narrowed 7,700 stocks to seven, with these four meeting strict efficiency and growth criteria.
  • Each stock also boasts higher asset utilization than its industry average and solid growth attributes.

Investors seeking strong returns may gain by adding stocks with robust liquidity to their portfolios. Liquidity reflects a company's ability to meet its short-term financial obligations. Stocks with high liquidity are favored by investors, as they often signal financial stability and the potential for strong growth and returns.

Investors may want to consider adding four top-ranked stocks — e.l.f. Beauty, Inc. (ELF - Free Report) , Hinge Health, Inc. (HNGE - Free Report) , MACOM Technology Solutions Holdings, Inc. (MTSI - Free Report) and Semtech Corporation (SMTC - Free Report) — to their portfolios to boost returns.

However, one should be alert enough before investing in such stocks. While a high liquidity level may imply that the company is clearing its dues faster than its peers, it may also indicate that the company is failing to use its assets efficiently. A balanced assessment of both liquidity and efficiency can help identify truly promising investment opportunities.

Measures to Identify Liquid Stocks

Current Ratio: It measures current assets relative to current liabilities. The ratio gauges a company’s potential to meet short- and long-term debt obligations. A current ratio — the working capital ratio — below 1 indicates that the company has more liabilities than assets. A high current ratio does not always suggest that the company is in good financial shape. It may also indicate that the firm failed to utilize its assets significantly. Hence, a range of 1-3 is considered ideal.

Quick Ratio: Unlike the current ratio, the quick ratio — the “acid-test ratio” or “quick assets ratio” — indicates a company’s ability to pay short-term obligations. It considers inventory, excluding current assets, relative to current liabilities. A quick ratio of more than 1 is desirable, like the current ratio.

Cash Ratio: This is the most conservative ratio among the three, considering cash, cash equivalents and invested funds relative to current liabilities. It measures a company’s ability to meet existing debt obligations using the most liquid assets. Though a cash ratio of more than 1 may suggest sound financials, a higher number may indicate inefficiency in cash utilization.

A ratio greater than 1 is always desirable, but it may not always represent a company’s financial condition.

Screening Parameters

To pick the best of the lot, we have added asset utilization — a widely used measure of a company’s efficiency — as one of the screening criteria. Asset utilization is the ratio of total sales in the past 12 months to the last four-quarter average of total assets. Though this ratio varies across industries, companies with a ratio higher than that of their industry can be considered efficient.

We added our proprietary Growth Score to the screen to ensure these liquid and efficient stocks have solid growth potential.

Current Ratio, Quick Ratio, and Cash Ratio between 1 and 3: While liquidity ratios greater than 1 are desirable, significantly high ratios may indicate inefficiency.

Asset utilization is more significant than the industry average: A higher asset utilization than the industry average indicates a company’s efficiency.

Zacks Rank equal to #1 (Strong Buy): Only Strong Buy-rated stocks can get through. You can see the complete list of today’s Zacks #1 Rank stocks here.

Growth Score less than or equal to B: Back-tested results show that stocks with a Growth Score of A or B handily beat other stocks when combined with a Zacks Rank #1 or 2 (Buy).

These criteria have narrowed the universe of more than 7,700 stocks to only seven.

Here are four of the seven stocks that qualified the screen:

e.l.f. Beauty is a multi-brand beauty company headquartered in Oakland, CA. It is focused on accessible, high-quality cosmetics and skincare. Its portfolio includes e.l.f. Cosmetics, e.l.f. SKIN, rhode, Naturium and Well People. 

The company recently reported second-quarter fiscal 2027 results, with net sales increasing 51% year over year to $520.8 million, marking its 31st consecutive quarter of revenue growth. Organic sales were up nearly 35%, while U.S. and international revenues increased 25% and 165%, respectively.

Strong demand across e.l.f. Cosmetics, rhode and Naturium brands, alongside retail expansion and international penetration bode well. The rhode brand achieved a record-breaking launch across 19 European countries through Sephora.

Encouraged by second-quarter performance, management raised its fiscal 2027 net sales guidance to $2.003 billion–$2.029 billion, representing 22%–24% growth, compared with the previous expectation of 18%–20%. Adjusted EBITDA is now projected in the range of $421 million–$427 million, up from $401 million–$407 million, while adjusted earnings guidance increased to $3.82–$3.86 per share from $3.50–$3.55.

The Zacks Consensus Estimate for ELF’s fiscal 2027 earnings sits at $3.89 per share, unchanged in the past seven days. The company has a Growth Score of B and an average trailing four-quarter earnings surprise of 80.46%.

Hinge Health is a digital musculoskeletal (MSK) care platform that combines AI-driven software, personalized therapy, remote coaching, and motion tracking to offer scalable care for large employers and health plans, reducing physical therapy costs.

The company reported impressive third-quarter 2026 results, with revenues increasing 52% year over year to $235 million. Last-12-month calculated billings advanced 54% to $960.3 million, while the number of contracted clients grew 28% to 3,270. 

While its core MSK business remains the foundation, the company is expanding into new avenues such as migraine care and gastrointestinal health.  The acquisition of Cylinder Health has strengthened its presence in gastrointestinal care, with GI clients increasing approximately 40% since the acquisition announcement. Meanwhile, its Migraine Care Program is witnessing expanding client adoption.

Hinge Health raised its 2026 revenue guidance to $879 million–$881 million from $856 million–$860 million, implying approximately 50% year-over-year growth at the midpoint. Non-GAAP operating income is now projected in the range of $266 million–$268 million. For the fourth quarter, management expects revenues of $249 million-$251 million and non-GAAP operating income of $81 million–$83 million.

The Zacks Consensus Estimate for HNGE’s 2026 earnings is pegged at $2.51 per share, unchanged in the past seven days. The company has a Growth Score of A and an average trailing four-quarter earnings surprise of 11.19%.

Macom Technology Solutions provides high-performance semiconductor solutions for the Industrial and Defense (“I&D”), Data Center and Telecommunications industries. 

The company recently reported fourth-quarter fiscal 2026 results, with revenues surging 62.7% year over year to $424.8 million. Data center revenues reached $188.1 million, increasing approximately 37% sequentially, while Industrial and Defense revenues increased 23% sequentially to $164.6 million.

Macom is benefiting from accelerated AI infrastructure investments and increasing adoption of high-speed optical connectivity. Management expects fiscal 2027 data center revenue growth to exceed the 74% achieved in fiscal 2026, driven by rising 1.6T optical deployments and higher semiconductor content opportunities. 

MACOM expects fiscal first-quarter 2027 revenues of $450 million–$460 million. Management anticipates approximately 15% sequential revenue growth in data center and single-digit growth in I&D, while telecom revenues are expected to remain flat to slightly lower. 

The Zacks Consensus Estimate for MTSI’s fiscal 2027 earnings is pegged at $8.96 per share, up 11 cents in the past seven days. The company has a Growth Score of B and an average trailing four-quarter earnings surprise of 3.47%.

Semtech manufactures high-performance semiconductor chips for AI data center networking and connected IoT devices. 

The company is benefiting from strong data-center demand, particularly across its FiberEdge, CopperEdge and emerging photonics portfolio. The company’s photonics portfolio includes semiconductor optical amplifiers, high-power lasers and high-speed photodiodes for scale-up, scale-out and scale-across data center connectivity applications.

Data-center revenues reached $100 million in the second quarter of fiscal 2027, up 39% sequentially and 91% year over year. The top line was supported by continued strength in 800G products and a ramp in 1.6T CopperEdge and the ramp of 1.6T FiberEdge. LoRa represents another major growth engine. LoRa-enabled net sales increased 31% sequentially and 58% year over year to $58 million. Growing traction for the LoRa Gen 4 platform, including LoRa Plus and other RF protocols, bodes well. 

On Oct. 15, 2026, at its Analyst Day, Semtech unveiled an ambitious fiscal 2030 financial framework targeting $3.2 billion in revenues, including $2.1 billion from its data center business, and adjusted EPS of $12.40-$13.00. The company also raised its third-quarter fiscal 2027 revenues and adjusted EPS outlook to $417.5 million and $1.14, respectively, at the midpoint.

The Zacks Consensus Estimate for SMTC’s fiscal 2027 earnings is pegged at $3.65 per share, unchanged in the past seven days. The company has a Growth Score of A and an average trailing four-quarter earnings surprise of 9.82%.

Published in